And the research supporting this delivery method, while promising, comes with important caveats that every informed researcher should understand before making the switch
We review warning signs and when to contact us
Glucagon-like peptide-1 (GLP-1) receptor agonistsincluding semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound)are FDA-approved medications for type 2 diabetes and chronic weight management
Contraindications include personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, and severe renal impairment
It's important to note that thyroid hormone should never be prescribed to treat obesity in people with normal thyroid function, as this is unsafe and carries an FDA boxed warning